Elena B. Kostova

Elena B. Kostova

Auto-generated profile, based on publicly available information

Elena B. Kostova

Center for Reproductive Medicine; Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
DBDjuna Z. de Back
Djuna Z. de Back
EKElena B. Kostova
Elena B. Kostova
MKMarian van Kraaij
Marian van Kraaij
Timo K. van den BergTimo K. van den Berg
Timo K. van den Berg
RBRobin van Bruggen
Robin van Bruggen
Macrophages tightly control the production and clearance of red blood cells (RBC). During steady state haematopoiesis, approximately 1010 red blood cells are produced per hour within erythroblastic islands in humans. In these erythroblastic islands, resident bone marrow macrophages provide erythroblasts with interactions that are essential for erythroid development. New evidence suggests that not only under homeostasis but also under stress conditions, macrophages play an important role in promoting erythropoiesis. Once RBC have matured, these cells remain in circulation for about 120 days. At the end of their life span, RBC are cleared by macrophages residing in the spleen and the liver. Current theories about the removal of senescent RBC and the essential role of macrophages will be discussed as well as the role of macrophages in facilitating the removal of damaged cellular content from the RBC. In this review we will provide an overview on the role of macrophages in the regulation of RBC production, maintenance and clearance. In addition, we will discuss the interactions between these two cell types during transfer of immune complexes and pathogens from RBC to macrophages.

13 August 2020 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
EFEloise Fraison
Eloise Fraison
EKElena Kostova
Elena Kostova
LMLisa J Moran
Lisa J Moran
SBSophia Bilal
Sophia Bilal
CECarolyn C Ee
Carolyn C Ee
MCMichael Costello
Michael Costello

28 November 2012 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
PBPatrick Burger
Patrick Burger
EKElena Kostova
Elena Kostova
EBEsther Bloem
Esther Bloem
PHPetra Hilarius‐Stokman
Petra Hilarius‐Stokman
AMAlexander B. Meijer
Alexander B. Meijer
RBRobin van Bruggen
Robin van Bruggen
During storage, erythrocytes undergo changes that alter their clearance and function after transfusion and there is increasing evidence that these changes contribute to the complications observed in transfused patients. Stored erythrocytes were incubated overnight at 37°C to mimic the temperature after transfusion. After incubation, several markers for erythrocyte damage were analysed. After overnight incubation, stored erythrocytes showed increased potassium leakage, haemolysis, PS exposure and vesicle formation, and all these effects increased with increasing storage time. Furthermore, we demonstrated that long-term stored erythrocytes develop decreased flippase activity and increased scrambling activity after overnight incubation, leading to PS exposure and the release of vesicles. Reduced intracellular potassium was identified as the cause of the decreased flippase activity. Lastly, we provide evidence that erythrocytes can return to a PS-negative state by shedding parts of their membrane as PS-containing vesicles and that these vesicles can serve as a platform for the coagulation cascade. These findings reveal that potassium leakage, a well-known phenomenon of prolonged erythrocyte storage, primes erythrocytes for PS exposure. PS exposure will lead to vesicle formation and might have an important impact on the post-transfusion function and side effects of stored erythrocytes.

16 January 2019 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
NWNienke S Weiss
Nienke S Weiss
EKElena Kostova
Elena Kostova
MNMarleen Nahuis
Marleen Nahuis
BMBen Willem J Mol
Ben Willem J Mol
FVFulco van der Veen
Fulco van der Veen
MWMadelon van Wely
Madelon van Wely

1 December 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
RJRositsa Jordanova
Rositsa Jordanova
MGMatthew Groves
Matthew Groves
EKElena Kostova
Elena Kostova
CWChristian Woltersdorf
Christian Woltersdorf
ELEva Liebau
Eva Liebau
PTPaul A. Tucker
Paul A. Tucker
Parasitic nematodes cause serious diseases in humans, animals, and plants. They have limited lipid metabolism and are reliant on lipid-binding proteins to acquire these metabolites from their hosts. Several structurally novel families of lipid-binding proteins in nematodes have been described, including the fatty acid- and retinoid-binding protein family (FAR). In Caenorhabditis elegans, used as a model for studying parasitic nematodes, eight C. elegans FAR proteins have been described. The crystal structure of C. elegans FAR-7 is the first structure of a FAR protein, and it exhibits a novel fold. It differs radically from the mammalian fatty acid-binding proteins and has two ligand binding pockets joined by a surface groove. The first can accommodate the aliphatic chain of fatty acids, whereas the second can accommodate the bulkier retinoids. In addition to demonstrating lipid binding by fluorescence spectroscopy, we present evidence that retinol binding is positively regulated by casein kinase II phosphorylation at a conserved site near the bottom of the second pocket. far-7::GFP (green fluorescent protein) expression shows that it is localized in the head hypodermal syncytia and the excretory cell but that this localization changes under starvation conditions. In conclusion, our study provides the basic structural and functional information for investigation of inhibitors of lipid binding by FAR proteins.

1 April 2015 in Bioscience Reports
Verified
Journal Article
Open access
PDF file
EKElena B. Kostova
Elena B. Kostova
BBBoukje M. Beuger
Boukje M. Beuger
TKThomas R.L. Klei
Thomas R.L. Klei
PHPasi Halonen
Pasi Halonen
CLCor Lieftink
Cor Lieftink
RBRobin van Bruggen
Robin van Bruggen
Even though red blood cell (RBC) vesiculation is a well-documented phenomenon, notably in the context of RBC aging and blood transfusion, the exact signalling pathways and kinases involved in this process remain largely unknown. We have established a screening method for RBC vesicle shedding using the Ca2+ ionophore ionomycin which is a rapid and efficient method to promote vesiculation. In order to identify novel pathways stimulating vesiculation in RBC, we screened two libraries: the Library of Pharmacologically Active Compounds (LOPAC) and the Selleckchem Kinase Inhibitor Library for their effects on RBC from healthy donors. We investigated compounds triggering vesiculation and compounds inhibiting vesiculation induced by ionomycin. We identified 12 LOPAC compounds, nine kinase inhibitors and one kinase activator which induced RBC shrinkage and vesiculation. Thus, we discovered several novel pathways involved in vesiculation including G protein-coupled receptor (GPCR) signalling, the phosphoinositide 3-kinase (PI3K)–Akt (protein kinase B) pathway, the Jak–STAT (Janus kinase–signal transducer and activator of transcription) pathway and the Raf–MEK (mitogen-activated protein kinase kinase)–ERK (extracellular signal-regulated kinase) pathway. Moreover, we demonstrated a link between casein kinase 2 (CK2) and RBC shrinkage via regulation of the Gardos channel activity. In addition, our data showed that inhibition of several kinases with unknown functions in mature RBC, including Alk (anaplastic lymphoma kinase) kinase and vascular endothelial growth factor receptor 2 (VEGFR-2), induced RBC shrinkage and vesiculation.